CDRH Plans Update To Procedures For Resolving Review Staff Disagreements
This article was originally published in The Gray Sheet
Executive Summary
FDA’s device center is responding to input from HHS’ Office of Inspector General, which was outlined in a June 5 report concluding that gaps remain in processes to ensure all relevant scientific opinions are heard within CDRH.